F. Tison, C. Keywood, Mark Wakefield
Sep 1, 2016
Citations
1
Influential Citations
100
Citations
Quality indicators
Journal
Movement Disorders
Abstract
The metabotropic glutamate receptor 5‐negative allosteric modulator dipraglurant reduces levodopa‐induced dyskinesia in the MPTP‐macaque model. The objective of this study was to assess the safety, tolerability (primary objective), and efficacy (secondary objective) of dipraglurant on levodopa‐induced dyskinesia in Parkinson's disease (PD).